Summit Therapeutics (SMMT) Return on Assets [ROA] (2020 - 2024)
Summit Therapeutics (SMMT) reported Return on Assets [ROA] of -50.02% for Q4 2024, up 239.31 percentage points from -289.33% a year earlier but down 1.42 percentage points from the prior quarter.
Summit Therapeutics (SMMT) Return on Assets [ROA] (2020 - 2024) Analysis & Trends
For FY2024, Summit Therapeutics posted Return on Assets [ROA] of -73.51%, up 68.32 percentage points from FY2023.
- Return on Assets [ROA] has a four-year change of -20.48 percentage points (FY2020 to FY2024).
- By year, Return on Assets [ROA] came in at -141.83% in FY2023 (-121.57 pp), -20.26% in FY2022 (+61.82 pp), -82.09% in FY2021 (-29.06 pp) and -53.03% in FY2020.
- Five-year quarterly Return on Assets [ROA] spans a low of -289.33% in Q4 2023 and a high of -17.59% in Q4 2022.
- Year over year, Return on Assets [ROA] has now increased in each of the last four quarters, with an average year-over-year change of +1.76 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q4 2024 (a gain of 239.31 percentage points); the low point was Q4 2023 (a drop of 271.73 percentage points).
- Per Business Quant data, the three quarters before Q4 2024 came in at -48.60% (Q3 2024), -63.60% (Q2 2024) and -62.15% (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Summit Therapeutics | 13.24 Bn | 11.00 Bn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -50.02% |
| Sep 30, 2024 | -48.60% |
| Jun 30, 2024 | -63.60% |
| Mar 31, 2024 | -62.15% |
| Dec 31, 2023 | -289.33% |
| Sep 30, 2023 | -260.50% |
| Jun 30, 2023 | -239.78% |
| Mar 31, 2023 | -127.76% |
| Dec 31, 2022 | -17.59% |
| Sep 30, 2022 | -62.85% |
| Jun 30, 2022 | -76.86% |
| Mar 31, 2022 | -81.16% |
| Dec 31, 2021 | -73.21% |
| Sep 30, 2021 | -54.74% |
| Jun 30, 2021 | -51.12% |
| Mar 31, 2021 | -52.65% |
| Dec 31, 2020 | -66.38% |
Summit Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SMMT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();